Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.

Keiichiro Suzuki; Mako Yamamoto; Reyna Hernandez-Benitez; Zhe Li; Christopher Wei; Rupa Devi Soligalla; Emi Aizawa; Fumiyuki Hatanaka; Masakazu Kurita; Pradeep Reddy; Alejandro Ocampo; Tomoaki Hishida; Masahiro Sakurai; Amy N Nemeth; Estrella Nuñez Delicado; Josep M Campistol; Pierre J. Magistretti; Pedro Guillen; Concepcion Rodriguez Esteban; Jianhui Gong; Yilin Yuan; Ying Gu; Guang-Hui Liu; Carlos López-Otín; Jun Wu; Kun Zhang; Juan Carlos Izpisua Belmonte

doi:10.1038/s41422-019-0213-0

Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.

Keiichiro Suzuki, Mako Yamamoto, Reyna Hernandez-Benitez, Zhe Li, Christopher Wei, Rupa Devi Soligalla, Emi Aizawa, Fumiyuki Hatanaka, Masakazu Kurita, Pradeep Reddy, Alejandro Ocampo, Tomoaki Hishida, Masahiro Sakurai, Amy N Nemeth, Estrella Nuñez Delicado, Josep M Campistol, Pierre J. Magistretti, Pedro Guillen, Concepcion Rodriguez Esteban, Jianhui GongYilin Yuan, Ying Gu, Guang-Hui Liu, Carlos López-Otín, Jun Wu, Kun Zhang, Juan Carlos Izpisua Belmonte

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Abstract

In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.

Original language	English (US)
Pages (from-to)	804-819
Number of pages	16
Journal	Cell research
Volume	29
Issue number	10
DOIs	https://doi.org/10.1038/s41422-019-0213-0
State	Published - Aug 23 2019

Bibliographical note

KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: We are grateful to M. Schwarz and P. Schwarz for administrative help; D. O’Keefe and S. Tsuji for help with manuscript preparation; M. Kay and Z.Y. Chen for sharing experimental materials; J. Naughton and J. Marlett for AAV production; K. Peterson and Y. Gu for helping the measurement of heart rate; U. Manor and K. Diffenderfer for imaging; K. McIntyre for mouse histology processing and J. Li for helping the molecular work; K. Sumiyama for data analysis. M.Y. was partially supported by 2016 Salk Women & Science Special Award. K.S. was supported by JSPS KAKENHI (15K21762 and 18H04036), Takeda Science Foundation, The Uehara Memorial Foundation, National Institutes of Natural Sciences (BS291007), The Sumitomo Foundation (170220), The Naito Foundation, The Kurata Grants (1350), Mochida Memorial Foundation, and The Inamori Foundation. This research was supported by Guangdong Provincial Key Laboratory of Genome Read and Write (No. 2017B030301011), Guangdong Provincial Academician Workstation of BGI Synthetic Genomics (No. 2017B090904014) and Shenzhen Peacock Plan (No. KQTD20150330171505310). J.C.I.B. was supported by The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the G. Harold and Leila Y. Mathers Charitable Foundation, NIH (R01HL123755 and 5 DP1 DK113616), The Progeria Research Foundation, The Glenn Foundation, KAUST, The Moxie Foundation, Fundación Dr. Pedro Guillen, AFE and Universidad Católica San Antonio de Murcia (UCAM).

Access to Document

10.1038/s41422-019-0213-0

Cite this

Suzuki, K., Yamamoto, M., Hernandez-Benitez, R., Li, Z., Wei, C., Soligalla, R. D., Aizawa, E., Hatanaka, F., Kurita, M., Reddy, P., Ocampo, A., Hishida, T., Sakurai, M., Nemeth, A. N., Nuñez Delicado, E., Campistol, J. M., Magistretti, P. J., Guillen, P., Rodriguez Esteban, C., ... Izpisua Belmonte, J. C. (2019). Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction. Cell research, 29(10), 804-819. https://doi.org/10.1038/s41422-019-0213-0

@article{65ab5dbe1d9f42219615eb786a487139,

title = "Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.",

abstract = "In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.",

author = "Keiichiro Suzuki and Mako Yamamoto and Reyna Hernandez-Benitez and Zhe Li and Christopher Wei and Soligalla, {Rupa Devi} and Emi Aizawa and Fumiyuki Hatanaka and Masakazu Kurita and Pradeep Reddy and Alejandro Ocampo and Tomoaki Hishida and Masahiro Sakurai and Nemeth, {Amy N} and {Nu{\~n}ez Delicado}, Estrella and Campistol, {Josep M} and Magistretti, {Pierre J.} and Pedro Guillen and {Rodriguez Esteban}, Concepcion and Jianhui Gong and Yilin Yuan and Ying Gu and Guang-Hui Liu and Carlos L{\'o}pez-Ot{\'i}n and Jun Wu and Kun Zhang and {Izpisua Belmonte}, {Juan Carlos}",

note = "KAUST Repository Item: Exported on 2020-10-01 Acknowledgements: We are grateful to M. Schwarz and P. Schwarz for administrative help; D. O{\textquoteright}Keefe and S. Tsuji for help with manuscript preparation; M. Kay and Z.Y. Chen for sharing experimental materials; J. Naughton and J. Marlett for AAV production; K. Peterson and Y. Gu for helping the measurement of heart rate; U. Manor and K. Diffenderfer for imaging; K. McIntyre for mouse histology processing and J. Li for helping the molecular work; K. Sumiyama for data analysis. M.Y. was partially supported by 2016 Salk Women & Science Special Award. K.S. was supported by JSPS KAKENHI (15K21762 and 18H04036), Takeda Science Foundation, The Uehara Memorial Foundation, National Institutes of Natural Sciences (BS291007), The Sumitomo Foundation (170220), The Naito Foundation, The Kurata Grants (1350), Mochida Memorial Foundation, and The Inamori Foundation. This research was supported by Guangdong Provincial Key Laboratory of Genome Read and Write (No. 2017B030301011), Guangdong Provincial Academician Workstation of BGI Synthetic Genomics (No. 2017B090904014) and Shenzhen Peacock Plan (No. KQTD20150330171505310). J.C.I.B. was supported by The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the G. Harold and Leila Y. Mathers Charitable Foundation, NIH (R01HL123755 and 5 DP1 DK113616), The Progeria Research Foundation, The Glenn Foundation, KAUST, The Moxie Foundation, Fundaci{\'o}n Dr. Pedro Guillen, AFE and Universidad Cat{\'o}lica San Antonio de Murcia (UCAM).",

year = "2019",

month = aug,

day = "23",

doi = "10.1038/s41422-019-0213-0",

language = "English (US)",

volume = "29",

pages = "804--819",

journal = "Cell research",

issn = "1001-0602",

publisher = "Springer Nature",

number = "10",

}

Suzuki, K, Yamamoto, M, Hernandez-Benitez, R, Li, Z, Wei, C, Soligalla, RD, Aizawa, E, Hatanaka, F, Kurita, M, Reddy, P, Ocampo, A, Hishida, T, Sakurai, M, Nemeth, AN, Nuñez Delicado, E, Campistol, JM, Magistretti, PJ, Guillen, P, Rodriguez Esteban, C, Gong, J, Yuan, Y, Gu, Y, Liu, G-H, López-Otín, C, Wu, J, Zhang, K & Izpisua Belmonte, JC 2019, 'Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.', Cell research, vol. 29, no. 10, pp. 804-819. https://doi.org/10.1038/s41422-019-0213-0

TY - JOUR

T1 - Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.

AU - Suzuki, Keiichiro

AU - Yamamoto, Mako

AU - Hernandez-Benitez, Reyna

AU - Li, Zhe

AU - Wei, Christopher

AU - Soligalla, Rupa Devi

AU - Aizawa, Emi

AU - Hatanaka, Fumiyuki

AU - Kurita, Masakazu

AU - Reddy, Pradeep

AU - Ocampo, Alejandro

AU - Hishida, Tomoaki

AU - Sakurai, Masahiro

AU - Nemeth, Amy N

AU - Nuñez Delicado, Estrella

AU - Campistol, Josep M

AU - Magistretti, Pierre J.

AU - Guillen, Pedro

AU - Rodriguez Esteban, Concepcion

AU - Gong, Jianhui

AU - Yuan, Yilin

AU - Gu, Ying

AU - Liu, Guang-Hui

AU - López-Otín, Carlos

AU - Wu, Jun

AU - Zhang, Kun

AU - Izpisua Belmonte, Juan Carlos

N1 - KAUST Repository Item: Exported on 2020-10-01 Acknowledgements: We are grateful to M. Schwarz and P. Schwarz for administrative help; D. O’Keefe and S. Tsuji for help with manuscript preparation; M. Kay and Z.Y. Chen for sharing experimental materials; J. Naughton and J. Marlett for AAV production; K. Peterson and Y. Gu for helping the measurement of heart rate; U. Manor and K. Diffenderfer for imaging; K. McIntyre for mouse histology processing and J. Li for helping the molecular work; K. Sumiyama for data analysis. M.Y. was partially supported by 2016 Salk Women & Science Special Award. K.S. was supported by JSPS KAKENHI (15K21762 and 18H04036), Takeda Science Foundation, The Uehara Memorial Foundation, National Institutes of Natural Sciences (BS291007), The Sumitomo Foundation (170220), The Naito Foundation, The Kurata Grants (1350), Mochida Memorial Foundation, and The Inamori Foundation. This research was supported by Guangdong Provincial Key Laboratory of Genome Read and Write (No. 2017B030301011), Guangdong Provincial Academician Workstation of BGI Synthetic Genomics (No. 2017B090904014) and Shenzhen Peacock Plan (No. KQTD20150330171505310). J.C.I.B. was supported by The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the G. Harold and Leila Y. Mathers Charitable Foundation, NIH (R01HL123755 and 5 DP1 DK113616), The Progeria Research Foundation, The Glenn Foundation, KAUST, The Moxie Foundation, Fundación Dr. Pedro Guillen, AFE and Universidad Católica San Antonio de Murcia (UCAM).

PY - 2019/8/23

Y1 - 2019/8/23

N2 - In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.

AB - In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.

UR - http://hdl.handle.net/10754/656597

UR - http://www.nature.com/articles/s41422-019-0213-0

UR - http://www.scopus.com/inward/record.url?scp=85071504608&partnerID=8YFLogxK

U2 - 10.1038/s41422-019-0213-0

DO - 10.1038/s41422-019-0213-0

M3 - Article

C2 - 31444470

SN - 1001-0602

VL - 29

SP - 804

EP - 819

JO - Cell research

JF - Cell research

IS - 10

ER -

Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this